| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,963 |
7,071 |
$535K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,820 |
3,381 |
$176K |
| 99443 |
|
1,196 |
1,059 |
$37K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,102 |
1,076 |
$33K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
415 |
394 |
$33K |
| 99358 |
Prolong nursin fac eval 15m |
347 |
305 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
632 |
625 |
$19K |
| 93000 |
|
1,129 |
1,085 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,986 |
1,898 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
178 |
174 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
65 |
64 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
327 |
310 |
$7K |
| 99215 |
Prolong outpt/office vis |
38 |
37 |
$4K |
| 81002 |
|
1,413 |
1,349 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
196 |
97 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
193 |
174 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
38 |
28 |
$389.50 |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
13 |
$233.23 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
12 |
$207.83 |
| 81025 |
|
12 |
12 |
$69.12 |